Vertex to Present at the Credit Suisse Healthcare Conference on November 7
03 November 2017 - 7:01AM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that management will present at the Credit Suisse
Healthcare Conference on Tuesday, November 7, 2017 at 10:35 a.m.
ET.
Management’s remarks will be available live through Vertex’s
website at www.vrtx.com in the “Investors” section under the “News
and Events” page. A replay of the conference webcast will be
archived on the company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious and life-threatening diseases. In addition to clinical
development programs in CF, Vertex has more than a dozen ongoing
research programs focused on the underlying mechanisms of other
serious diseases.
Founded in 1989 in Cambridge, Mass., Vertex's headquarters is
now located in Boston's Innovation District. Today, the company has
research and development sites and commercial offices in the United
States, Europe, Canada and Australia. Vertex is consistently
recognized as one of the industry's top places to work, including
being named to Science magazine's Top Employers in the life
sciences ranking for eight years in a row.
For additional information and the latest updates from the
company, please visit www.vrtx.com.
(VRTX-WEB)
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171102006530/en/
Vertex Pharmaceuticals
IncorporatedInvestors:Michael Partridge,
617-341-6108orEric Rojas, 617-961-7205orZach Barber,
617-341-6470
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2024 to May 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From May 2023 to May 2024